Azacitidine for the treatment of patients with acute myeloid leukemia with 20%-30% blasts and multilineage dysplasia.
about
Azacitidine for the treatment of patients with acute myeloid leukemia with 20%-30% blasts and multilineage dysplasia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@ast
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@en
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@nl
type
label
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@ast
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@en
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@nl
prefLabel
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@ast
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@en
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@nl
P2860
P1433
P1476
Azacitidine for the treatment ...... ts and multilineage dysplasia.
@en
P2093
Patricia Font
P2860
P2888
P356
10.1007/S12325-011-0002-8
P407
P478
28 Suppl 3
P577
2011-03-09T00:00:00Z
P5875
P6179
1045916239